European Pharmaceutical Review

OCTOBER 9, 2022

Research published in the journal Nature Chemistry , shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol tiglate, named EBC-46, which could offer targeted medicine for cancer and other diseases. Natural sources of the compound can only be found in a small section of the Northeastern Australia rainforest, in fruit seeds from the blushwood tree ( Fontainea picrosperma ).

Food and Drug Administration 141

Food and Drug Administration Medicine Food Pharmaceutical 141

MedCity News

OCTOBER 14, 2022

Moving to value-based care models isn’t easy. But payers may be in the best position to make this change, according to the Business Group on Health. Employers, meanwhile, can encourage their employees to receive care from providers participating in value-based care.

136

136

pharmaphorum

OCTOBER 14, 2022

A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division Janssen – has been set up to tackle the environmental impact of digital health products, specifically aimed at minimising waste that could end up in landfill. The Digital Health in a Circular Economy (DiCE) group was formed earlier this year with the aim of developing ways to “design, collect, directly reuse, refurbish, remanufacture, and recycle digital health devices.” The programme

Leads 119

Leads Electronics Ethics Healthcare 119

Medgadget

OCTOBER 11, 2022

Researchers at the University of California San Francisco have developed a suite of video games that have been designed to improve cognition in older adults who are otherwise healthy. The games aim to recreate common activities, such as banging a drum or driving a car. They also include a sophisticated algorithm that automatically adjusts the game difficulty depending on how well someone is playing, helping to stop less skilled players from becoming overwhelmed and more skilled players from beco

Training 116

Training Medicine 116

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

European Pharmaceutical Review

OCTOBER 13, 2022

Scientists at MIT have demonstrated that a novel robotic capsule could potentially replace conventional biologic injection methods by tunnelling through the intestinal mucus barrier to deliver insulin. The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide.

Transportation 137

Transportation Engineering Leads Medical 137

MedCity News

OCTOBER 11, 2022

In response to emailed questions, executives from Biofourmis, Force Therapeutics and Project Ronin shared products they’re developing in remote patient monitoring as part of the broader hospital at home trend.

Patients 128

Patients 128

Medgadget

OCTOBER 11, 2022

At Johns Hopkins, clinical researchers have developed a set of surgical tools that allow them to more easily create a replacement ear for those born with malformed or missing ears. Currently, using cartilage harvested from the ribs, surgeons can create a new ear, but the process is difficult and requires some artistic talent to sculpt the cartilage into the right shape.

Medicine 115

Medicine Patients 115

European Pharmaceutical Review

OCTOBER 14, 2022

RemeGen has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for its proprietary novel fusion protein Telitacicept (RC18) for the treatment of myasthenia gravis (MG). Telitacicept is a proprietary novel fusion protein from RemeGen to treat autoimmune diseases. It is constructed with the extracellular domain of the human transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) receptor and the fragment crystallisable

Food and Drug Administration 121

Food and Drug Administration Side effects FDA Food 121

MedCity News

OCTOBER 13, 2022

Providence issued a response to a letter sent by Sen. Patty Murray of Washington, in which she demanded the health system answer questions about its alleged efforts to aggressively bill patients who qualified for free or discounted care. The response denied that Providence aggressively pursued its poorest patients for medical debt, asserting that its “commitment to those in need has never been stronger.”.

Medical 122

Medical Patients Healthcare Healthcare 122

pharmaphorum

OCTOBER 11, 2022

An intranasal formulation of AstraZeneca’s widely-used COVID-19 vaccine Vaxzevria has failed at the first hurdle, after results from a phase 1 trial found it was unable to stimulate a strong immune response to the virus. The 30-subject study – funded by AZ and published in the Lancet journal eBioMedicine – tested two strengths of the current formulation of the vaccine administered as a nasal spray, with half the group receiving a second intranasal dose 28 days later, and half getting a reg

Patients 108

Patients 108

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaVoice

OCTOBER 10, 2022

Companies like Pfizer, Novartis, Sanofi and BMS are diving into the world of digital therapeutics while recognizing the limitations of the young field.

Pharma 116

Pharma 116

Star OUTiCO

OCTOBER 13, 2022

Star OUTiCO, as part of the Uniphar Group Commercial & Clinical division, is getting ready for this year’s group Unity for Hope initiative, raising vital funds for seven cancer charities across Ireland, the UK, US, and Australia. Launching on Monday 24 th October, Unity for Hope will see companies spread across the Uniphar Group aim to raise an impressive €100k – to be matched by Uniphar up to a further €100k, by reaching 15,000,000 steps – or equivalent cycle rotations – d

Sales Management 98

Sales Management Training Sales Management 98

MedCity News

OCTOBER 11, 2022

How do organizations optimize and scale business intelligence? Here are five basic steps to consider when developing dashboards to assess your operational, financial and quality components within the care at home industry.

Management 122

Management 122

pharmaphorum

OCTOBER 10, 2022

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. The National Institutes of Health (NIH), which oversees disease research, has a total annual budget equivalent to $120 per person, with only $0.19 per person being spent on food allergy research.

Food 102

Food Healthcare Healthcare Electronics 102

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

PharmaVoice

OCTOBER 12, 2022

As the Healthcare Businesswomen’s Association’s first chief people and DEI officer, Jones is poised to tackle pay gap inequity, systemic gender bias and leadership barriers impeding women of color.

Healthcare 105

Healthcare Healthcare 105

PharmExec

OCTOBER 11, 2022

Bristol Myers Squibb commercial head Chris Boerner believes a straightforward formula is the best formula in advancing innovation and developing talent in today’s complex healthcare climate—an approach he roots in authenticity and “not over engineering,” whether tackling business or culture.

Engineering 98

Engineering Healthcare Healthcare 98

MedCity News

OCTOBER 11, 2022

Cybercriminals are weaponizing the same tools that healthcare providers use to operate and maintain secure IT systems, HHS warned in a recent report. Providers can protect themselves by having a firm grasp of what their IT environment looks like, as this may help them spot any suspicious security tool commands.

Healthcare Provider 122

Healthcare Provider Healthcare Healthcare 122

pharmaphorum

OCTOBER 12, 2022

It’s no secret that the healthcare system is made up of a panoply of diverse stakeholders, each with their own priorities, incentives, and motivations. Bringing those stakeholders together is an oft-lauded goal, but it’s proved easier said than done. The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine.

Medicine 101

Medicine Training Education Healthcare 101

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

OCTOBER 10, 2022

While there are many sources of real-world evidence, there’s growing interest and focus on capturing patient generated insights to capture a more specific level of understanding for a given therapy.

Patients 98

Patients 98

Celeritas

OCTOBER 12, 2022

Over the last decade, the US BioTech and Pharma industries have truly flourished, with pharma-related discoveries and innovations growing at an increasing rate. In line with this trend, there is building pressure on HCPs to adopt newer processes and prescribe advanced medication. Due to rigid FDA regulations, however, pharma financial resources are often depleted in generating drugs which fail to pass the approval process.

Pharma 98

Pharma Marketing Sales Sales presentations 98

MedCity News

OCTOBER 11, 2022

Rethinking the entire patient-as-consumer experience to create something that’s pure, clean, modern and friendly is a fundamental requirement for building and maintaining their brand.

Patients 120

Patients Healthcare Healthcare Marketing 120

PharmExec

OCTOBER 11, 2022

Pharma supply chains are no longer hidden beyond the reach of ESG agendas, making it important for companies to accelerate adoption of new manufacturing processes and environmental technology.

Pharma 98

Pharma Manufacturing 98

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Medico Reach

OCTOBER 10, 2022

Surgical Instrument Companies are expanding steadily, with a considerable number of new companies joining the market every year. To distinguish them from their competitors, American medical and surgical equipment firms must provide high-quality, long-lasting medical instruments, build and maintain their reputation, and promote efficient and straightforward communication with consumers.

Manufacturing 98

Manufacturing Medical Education Specialization 98

European Pharmaceutical Review

OCTOBER 10, 2022

The Centre for Process Innovation (CPI) was granted £10.65 million to support its work in development, scale-up and manufacture of RNA therapies and finance the training centre already established at the site, which aims to upskill the future RNA workforce. The RNA Centre of Excellence is the only UK site equipped to develop and manufacture millions of doses of a messenger and self-amplifying RNA vaccines.

Training 98

Training Manufacturing Medicine Pharma 98

MedCity News

OCTOBER 12, 2022

This dearth of maternity care providers is exacerbating the country’s less-than-stellar reputation for birth outcomes. In order to ensure better health for mothers and their newborns, OB-GYNs must identify risk factors that negatively impact pregnancy early on and work to maintain the whole picture of their pregnant patients’ health. However, OB-GYNs aren’t incentivized to do this under a fee-for-service payment model.

Patients 117

Patients 117

Medgadget

OCTOBER 13, 2022

Researchers at Carnegie Mellon University have used a nanoscale 3D printing technique that allows them to customize the microelectrode arrays used for brain computer interfaces. The approach is called Aerosol Jet 3D printing, and the researchers used it to create three-dimensional microelectrode arrays that can be customized for particular patient needs.

Electronics 96

Electronics Patients Medicine 96

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Legacy MEDSearch

OCTOBER 14, 2022

ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced the FDA has given 510(k) clearance of its Flux-C 3D printed porous titanium cervical interbody device. “Surgeons have many options for cervical interbodies. The Flux-C porous titanium device offers one of the best in class with superior endplate contact and spaces for generous inter-device bone grafting.

Medical 95

Medical Recruitment Manufacturing Management 95

Pharmatutor

OCTOBER 13, 2022

DRUG REPURPOSING : A REVIEW. About Authors 1 AGARWAL POONAM*, 2 RATHORE KAMAL SINGH, KAVITA VIJAY 2 1 Department of Pharmaceutics, Bhopal Nobles’ Collage of Pharmacy Udaipur, Rajasthan, 2 Faculty, Jaipur, College of Pharmacy, Jaipur India, 313001. Email : charmiagarwal823@gmail.com. admin. Thu, 10/13/2022 - 15:56. Tags. Articles. Review Articles.

Pharmaceutical 95

Pharmaceutical 95

MedCity News

OCTOBER 14, 2022

A nationwide railroad strike could be coming mid-November. There are some key considerations that healthcare providers should take note of while they anticipate the possibility of a this strike, including having proactive conversations with their suppliers and identifying product alternatives.

Healthcare Provider 116

Healthcare Provider Healthcare Healthcare 116

European Pharmaceutical Review

OCTOBER 13, 2022

Astellas will present results from a Phase III clinical study evaluating fezolinetant, an investigational oral, non-hormonal compound being studied to potentially treat vasomotor symptoms (VMS) associated with menopause. Fezolinetant is designed as a selective neurokinin 3 (NK3) receptor antagonist. The SKYLIGHT 4 trial results demonstrate the 52-week safety and tolerability of fezolinetant 30mg and 45mg administered once daily.

Safety 97

Safety Medicine Pharmaceutical Marketing 97

Advertiser: ZoomInfo

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.

Marketing